Influence of the Prostate Cancer Prevention Trial on finasteride prescribing in the veterans health administration

被引：0
|
作者：
Hamilton, Robert J.
Kahwati, Leila C.
Krupski, Tracey L.
Harris, Russell
Kinsinger, Linda S.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60199-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [21] Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial
    Unger, Joseph M.
    Hershman, Dawn L.
    Till, Cathee
    Tangen, Catherine M.
    Barlow, William E.
    Ramsey, Scott D.
    Goodman, Phyllis J.
    Thompson, Ian M., Jr.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (11): : 1208 - 1215
  • [22] Clinical pharmacist prescribing activities in the Veterans Health Administration
    Ourth, Heather
    Groppi, Julie
    Morreale, Anthony P.
    Quicci-Roberts, Kimberly
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (18) : 1406 - 1415
  • [23] Gender Differences in Prescribing of Zolpidem in the Veterans Health Administration
    Jasuja, Guneet K.
    Reisman, Joel I.
    Wiener, Renda Soylemez
    Christopher, Melissa L.
    Rose, Adam J.
    AMERICAN JOURNAL OF MANAGED CARE, 2019, 25 (03): : E58 - +
  • [24] Prevention of prostate cancer with finasteride: US/European perspective
    Thompson, IM
    Klein, EA
    Lippman, SM
    Coltman, CA
    Djavan, B
    EUROPEAN UROLOGY, 2003, 44 (06) : 650 - 655
  • [25] Detection bias due to the effect of Finasteride on prostate volume: A modeling approach for analysis of the prostate cancer prevention trial
    Cohen, Yael C.
    Liu, Kenneth S.
    Heyden, Norman L.
    Carides, Alexandra D.
    Anderson, Keaven M.
    Daifotis, Anastasia G.
    Gann, Peter H.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (18): : 1366 - 1374
  • [26] Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2018, 199 (01): : 7 - 8
  • [27] Does the level of prostate cancer risk affect cancer prevention with finasteride?
    Thompson, Ian M.
    Tangen, Catherine M.
    Parnes, Howard L.
    Lippman, Scott M.
    Coltman, Charles A., Jr.
    UROLOGY, 2008, 71 (05) : 854 - 857
  • [28] Long-term effects of finasteride on prostate specific antigen levels: Results from the Prostate Cancer Prevention Trial
    Etzioni, RD
    Howlader, N
    Shaw, PA
    Ankerst, DP
    Penson, DF
    Goodman, PJ
    Thompson, IM
    JOURNAL OF UROLOGY, 2005, 174 (03): : 877 - 881
  • [29] Gender Differences in Prescribing of Zolpidem in the Veterans Health Administration (VHA)
    Jasuja, G.
    Reisman, J.
    Wiener, R.
    Christopher, M.
    Rose, A.
    HEALTH SERVICES RESEARCH, 2020, 55 : 79 - 79
  • [30] Impact of hydrocodone reclassification on analgesic prescribing in the Veterans Health Administration
    Steckler, Taylor J.
    Mosher, Hilary J.
    Desloover-Koch, Yvonne
    Lund, Brian C.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 : S61 - S67
12345